Earnings Feed
Start Free
Home/Insiders/Gupta Amit
GA
SEC Insider//CIK 0001961238

Gupta Amit

CIK 00019612381 companyATLANTA, GA
SEC Profile

Transactions

50

Companies

1

Filings

6

CIK

0001961238

Recent Transactions

50 trades
  • Sale
    Cardlytics, Inc.$CDLX

    Common Stock

    2026-01-05$1.17/sh−5,807→ 506,852 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Units

    2026-01-01−14,349→ 14,350 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2026-01-01+14,349→ 512,659 total
  • Sale
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-10-02$2.27/sh−7,799→ 498,310 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Units

    2025-10-01−14,350→ 28,699 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-10-01+14,350→ 506,109 total
  • Sale
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-08-19$1.12/sh−68,685→ 491,759 total
  • Sale
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-08-18$1.13/sh−68,260→ 560,444 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-08-18+125,000→ 628,704 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-08-18+125,000→ 503,704 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Units

    2025-08-16−125,000→ 250,000 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Units

    2025-08-16−125,000→ 250,000 total
  • Sale
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-07-02$1.78/sh−6,725→ 378,704 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Units

    2025-07-01−14,349→ 43,049 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-07-01+14,349→ 385,429 total
  • Award
    Cardlytics, Inc.$CDLX

    Restricted Stock Units

    2025-06-23+1,000,000→ 1,000,000 total
  • Award
    Cardlytics, Inc.$CDLX

    Performance Stock Unit

    2025-06-23+300,000→ 300,000 total
  • Sale
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-04-02$1.81/sh−7,342→ 371,080 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Units

    2025-04-01−14,350→ 57,398 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-04-01+14,350→ 378,422 total
  • Sale
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-02-19$3.18/sh−54,565→ 364,072 total
  • Sale
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-02-18$3.40/sh−46,857→ 418,637 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-02-16+125,000→ 465,494 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Units

    2025-02-16−125,000→ 375,000 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Units

    2025-02-16−125,000→ 375,000 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-02-16+125,000→ 340,494 total
  • Award
    Cardlytics, Inc.$CDLX

    Restricted Stock Units

    2025-01-29+500,000→ 500,000 total
  • Sale
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-01-24$3.92/sh−15,160→ 215,494 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-01-23+43,750→ 230,654 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Unit

    2025-01-23−43,750→ 0 total
  • Sale
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-01-03$3.67/sh−5,964→ 186,904 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Units

    2025-01-01−14,349→ 71,748 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-01-01+14,349→ 192,868 total
  • Sale
    Cardlytics, Inc.$CDLX

    Common Stock

    2024-10-24$3.85/sh−22,607→ 178,519 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2024-10-23+43,750→ 201,126 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Unit

    2024-10-23−43,750→ 43,750 total
  • Sale
    Cardlytics, Inc.$CDLX

    Common Stock

    2024-10-02$3.08/sh−7,543→ 157,376 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Units

    2024-10-01−14,350→ 86,097 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2024-10-01+14,350→ 164,919 total
  • Award
    Cardlytics, Inc.$CDLX

    Restricted Stock Units

    2024-08-21+500,000→ 500,000 total
  • Sale
    Cardlytics, Inc.$CDLX

    Common Stock

    2024-07-24$8.66/sh−22,699→ 150,569 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Unit

    2024-07-23−43,750→ 87,500 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2024-07-23+43,750→ 173,268 total
  • Sale
    Cardlytics, Inc.$CDLX

    Common Stock

    2024-07-02$7.95/sh−7,507→ 129,518 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Units

    2024-07-01−14,349→ 100,447 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2024-07-01+14,349→ 137,025 total
  • Sale
    Cardlytics, Inc.$CDLX

    Common Stock

    2024-04-24$11.91/sh−23,416→ 122,676 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2024-04-23+43,750→ 146,092 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Unit

    2024-04-23−43,750→ 131,250 total
  • Award
    Cardlytics, Inc.$CDLX

    Restricted Stock Units

    2024-03-22+114,796→ 114,796 total

Companies

1

Recent Filings

6

Address

675 PONCE DE LEON AVENUE NE SUITE 4100

ATLANTA, GA, 30308

View on SEC.gov